Pediatric occipital lobe epilepsy: A modern review of etiological classification, management, and outcomes

Table 6 Drugs for long term management of occipital lobe epilepsy

Drug	Indication in OLE	Clinical summary	Safety and considerations	Level of evidence
Carbamazepine	First-line: COVE (Gastaut type); focal seizures.	High seizure-control rates in idiopathic cohorts; approximately 70% seizure-free in ICOE-G[35]	Enzyme inducer; may aggravate certain structural OLE. Not preferred in photosensitive forms	IIb-IV (pediatric observational; no RCT)[35]
Valproate	POLE; OLE with photosensitivity or generalized features	Superior seizure-free rates in mixed OLE cohorts	Critical: Contraindicated in adolescent females; restricted in patients < 55 years per 2025 regulatory updates. Teratogen; hepatotoxicity risk in young children	IIb-V (extrapolated; avoid in females)[30]
Levetiracetam	First-line/adjunct: SeLEAS and COVE	Broad spectrum; high preference in recent pediatric cohorts. Non-inferior to CBZ in focal epilepsy RCT[32]	Minimal drug interactions. Monitor for behavioral irritability/mood changes (20%-40% in children)	Ib (adult RCT; pediatric cohorts)[32]
Lamotrigine	Adjunct: COVE/SeLEAS; alternative to VPA in females	Favored for POLE; good cognitive profile. Effective for focal seizures	Requires slow titration (6-8 weeks). Risk of Stevens-Johnson syndrome, especially if co-prescribed with VPA	IIb-V (focal epilepsy cohorts)[30]
Topiramate	Adjunct: Drug-resistant OLE; comorbid migraine	Lower seizure-freedom rates vs VPA or CBZ in OLE. Useful in photosensitive POLE and migraine comorbidity	Risk of cognitive slowing and word-finding difficulty; monitor school performance. Weight loss	IIb-V (focal epilepsy cohorts)[31]
Benzodiazepines	Acute rescue: Prolonged SeLEAS seizures; status epilepticus	Strong evidence for acute seizure termination (IV lorazepam/IM midazolam). First-line for convulsive status[41]	Chronic use limited by sedation and tolerance. Clear home-rescue plan essential for SeLEAS families	Ia (status epilepticus guideline)[41]

COVE: Childhood occipital visual epilepsy; SeLEAS: Self-limited epilepsy with autonomic seizures; POLE: Photosensitive occipital lobe epilepsy; VPA: Valproate; CBZ: Carbamazepine; OLE: Occipital lobe epilepsy; RCT: Randomized controlled trials; ICOE-G: Idiopathic childhood occipital epilepsy of Gastaut.